Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign prostatic hyperplasia: solutions to an ageing problem.

Charlotte L Foley1, Simon R J Bott, Manit Arya

  • 1Institute of Nephrology and Urology, University College London, London W1W 7EJ.

Hospital Medicine (London, England : 1998)
|September 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer.

JAMA oncology·2026
Same author

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines.

Molecular oncology·2025
Same author

The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations.

European urology·2024
Same author

The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.

European urology·2023
Same author

Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.

Journal of medical economics·2023
Same author

External validation of a risk model predicting failure of salvage focal ablation for prostate cancer.

BJU international·2023
Same journal

Management of non-thrombolysable acute coronary syndrome (ACS).

Hospital medicine (London, England : 1998)·2005
Same journal

Case report: treatment of faecaloma of the colon.

Hospital medicine (London, England : 1998)·2005
Same journal

Should anaesthetists scrub? The case for and against.

Hospital medicine (London, England : 1998)·2005
Same journal

Angiosarcoma: a difficult diagnosis.

Hospital medicine (London, England : 1998)·2005
Same journal

Pitfalls in recurrent varicose vein surgery.

Hospital medicine (London, England : 1998)·2005
Same journal

Aorto-caval fistula.

Hospital medicine (London, England : 1998)·2005
See all related articles

As the population ages, treatments for benign prostatic hyperplasia symptoms are increasingly sought. This review examines available medical and surgical options for managing this condition.

Area of Science:

  • Urology
  • Geriatrics
  • Pharmacology

Background:

  • Aging populations are experiencing a higher incidence of benign prostatic hyperplasia (BPH).
  • The demand for effective BPH symptom management is escalating globally.
  • A wide array of therapeutic interventions for BPH is now available.

Purpose of the Study:

  • To review and summarize current medical and surgical treatment options for benign prostatic hyperplasia.
  • To provide an overview of the evolving landscape of BPH therapies.
  • To inform healthcare providers and patients about the choices in BPH management.

Main Methods:

  • Literature review of peer-reviewed articles and clinical guidelines.
  • Synthesis of evidence on medical therapies (e.g., alpha-blockers, 5-alpha-reductase inhibitors).

Related Experiment Videos

  • Analysis of surgical interventions (e.g., TURP, minimally invasive procedures).

    • Main Results:

    • Medical treatments offer symptomatic relief for many BPH patients.
    • Surgical options provide definitive solutions with varying risk profiles.
    • Treatment selection depends on symptom severity, patient comorbidities, and preferences.

    Conclusions:

    • A comprehensive range of medical and surgical treatments exists for benign prostatic hyperplasia.
    • Personalized treatment strategies are essential for optimal BPH management.
    • Continued research is vital to refine existing therapies and develop novel approaches for BPH.